marginally non-significantp = 0.05
A meta-analysis of six randomized controlled trials investigating the efficacy of incorporating VR into PR for patients with COPD noted that VR enhanced the therapeutic effects of PR with significant improvements in FEV1 ( p < 0.05) and marginally non-significant improvements in 6MWT ( p = 0.05) [ 84 ].